← All trials
NCT01382472
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2011
- Primary completion
- Dec 1, 2016
- Completion date
- Dec 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of StavangerLead sponsor
- University Hospital of North NorwayOverall official - principal investigator
- University of StavangerOverall official - principal investigator
- Norwegian University of Science and TechnologyOverall official - principal investigator
- University Hospital of North NorwayCollaborator
- Norwegian University of Science and TechnologyCollaborator
- Western Norway Regional Health AuthorityCollaborator
- University of StavangerStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.